CLEVELAND and RALEIGH, N.C., March 23, 2016 -- Industrial Origami Inc. has retained Adapt IP Ventures to monetize its expansive portfolio of “foldable” metal fabrication technologies. With 65 patents assets across 13 jurisdictions, Industrial Origami’s underlying technology promotes the ability to fold lighter gauge material into complex, innovative, high load-bearing structures at the point of assembly.
Industrial Origami’s IP portfolio (which spans the jurisdictions of the United States, China, Japan, South Korea, Taiwan, India, EPO, United Kingdom, Sweden, France, Italy, Brazil, and Mexico), along with Industrial Origami’s proprietary software and soft tooling systems, currently remain available for license or for sale.
Since their founding in the early 2000s, Industrial Origami’s patented technology and processes have typically saved their customers anywhere from 20% to 70% on costs when compared to traditional sheet metal manufacturing, specifically across cost of goods, production time, and sustainability measures, because:
- Their process allows for the use of thinner-gauge metals.
- Their process requires less welding and fewer fasteners.
- Production can be rapidly scaled, from prototype to high volume production, which reduces significant new product tooling costs.
- Delivery costs are reduced because stamped metal can be shipped and stored flat before being folded by the end user.
- Their technologies are more “recyclable” - these metal structures offer an opportunity for an acceptable return on investment and a lower overall cost than single-use packaging products.
Historically, Industrial Origami’s patented technology has been deployed across a diverse set of applications ranging from automotive, solar racking, packing, electrical enclosures, HVAC, and appliances. In the automotive field, Industrial Origami’s technology was used to develop a Mazda funded “concept car” for a fraction of typical prototyping costs. In a solar application, Industrial Origami further developed a low cost, innovative fixed tilt PV Ground Mount System specifically designed to minimize PV racking material costs and installation labor (60% faster than normal labor) for large commercial and utility scale installations. For a large appliance manufacturer, Industrial Origami’s technology afforded material cost savings generally between 25%-45% across a whole series of home appliances.
Adapt IP Ventures anticipates marketing the Industrial Origami patent portfolio offering through the summer of 2016. Accordingly, all interested parties looking to gather more information about this offering, either for license, sale, or other business development purposes, should contact Brian Bochicco at [email protected] or Grant Moss at [email protected].
About Adapt IP Ventures, LLC
Adapt IP Ventures provides transaction advisory services designed to assist individual inventors, companies and universities understand and extract value from their patents. Typical engagements consist of Adapt IP Ventures developing and executing custom strategies to sell, license patents or acquire patents. For more information, please visit www.adaptipventures.com.


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



